Dec 15,2022

New Data Presented at the 2022 San Antonio Breast Cancer Symposium Shows Early Detection using L-Dex and Intervention Improves Lymphedema Progression-Free Survival

ImpediMed Limited is pleased to announce a poster showing that breast cancer patients receiving early detection of lymphedema using ImpediMed's L-Dex® technology and intervention had statistically higher rates of lymphedema progression-free survival through three years compared to using tape measure was presented at the 2022 San Antonio Breast Cancer Symposium on December 6-10, 2022 in San Antonio, Texas. The primary aim of the PREVENT Trial was published in January 2022 and demonstrated that patients with early detection using L-Dex and at-home intervention with compression garments resulted in a 7.9% rate of chronic lymphedema compared to a 19.2% rate of chronic lymphedema using tape measure.

CLINICAL STUDY

#ai/software

View Analyst & Ambassador Comments
Go to original news
Dec 20,2022

Fujifilm to acquire Inspirata’s digital pathology business

Fujifilm announced today that it entered into an asset purchase agreement for the global digital pathology business of Inspirata. Upon completing the agreement, Fujifilm absorbs Inspirata’s Dynamyx digital pathology technology. “Acquiring Inspirata’s digital pathology business allows Fujifilm to be an even stronger healthcare partner – bridging a technological gap between pathology, radiology and oncology to facilitate a more collaborative approach to care delivery across the enterprise,” said Teiichi Goto, president and CEO, representative director, Fujifilm.

COLLABORATION MERGERS & ACQUISITION

#product & service

#ai/software

View Analyst & Ambassador Comments
Go to original news
Dec 21,2022

Implementing a web-based system of screening for symptoms and needs using patient-reported outcomes in people with cancer

The purpose of this study is to evaluate the implementation of a web-based system of screening for symptoms and needs in people with diverse cancers in a general hospital in Australia. Screening for symptoms and needs using a web-based portal identified many unmet needs, but the uptake of this intervention by nurses and patients was lower than expected.

CLINICAL STUDY

#telehealth

View Analyst & Ambassador Comments
Go to original news
Dec 22,2022

Massive Bio Supports Cancer Associations

Massive Bio announced the launch of “Donation for Life,” a new awareness campaign created to support cancer associations and foundations in the United States and Europe.

View Analyst & Ambassador Comments
Go to original news
Dec 27,2022

A systematic review of m-health apps on managing side effects of breast cancer treatment

After breast cancer treatment, women with breast cancer may experience distress caused by treatment side effects, both in physical and psychological aspects. Technology use is increasing in favor among women. Therefore, it is essential to update the scientific evidence regarding mobile and web apps’ effectiveness in managing the side effects of breast cancer treatments for breast cancer survivors. The purpose of this systematic review was to investigate the scientific evidence on the effectiveness of mobile and web apps in managing the side effects of breast cancer treatments among this group.

CLINICAL STUDY

#mobile app

View Analyst & Ambassador Comments
Go to original news
Dec 29,2022

Jasper Health Year in Review 2022

As 2022 comes to a close, the company reflects on all that has happened this year at Jasper Health to move their mission of creating a better cancer care experience for all forward. From completing their $25M Series A funding in February, led by General Catalyst and other investors (Human Capital, W Health Ventures, Redesign Health, and 7wireVentures) to launching a partnership with Walgreens this past summer, the first half of the year was an exciting one for the company. In the second half of the year Jasper Health announced working with one of the world’s most renowned comprehensive cancer centers, Memorial Sloan Kettering. Finally, Jasper Health’s news of being available through the Evernorth Digital Formulary to enhance the lives of those affected by cancer, is a huge accomplishment in achieving their mission.

View Analyst & Ambassador Comments
Go to original news
Dec 30,2022

Effect and feasibility of gamification interventions for improving physical activity and health-related outcomes in cancer survivors: an early systematic review and meta-analysis

Despite the well-documented advantages of regular physical activity (PA), patients with cancer show suboptimal participation. By using game design elements, gamification could be used to motivate individuals to engage in PA. There are, however, inconsistent findings regarding the impact of gamification interventions on cancer survivors’ PA and health-related outcomes, according to the literature. The aim of this study is to examine the effectiveness and feasibility of gamification interventions for improving physical activity (PA) and health-related outcomes among cancer survivors.

CLINICAL STUDY

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jan 24,2023

Curebase Launches All-in-One Software and Trial Execution Package to Help Digital Therapeutics Companies Accelerate Clinical Trials

Curebase, a company committed to democratizing access to clinical trials, announced the release of its integrated software and services package for digital therapeutics (DTx) trials that accelerates enrollment and allows sponsors to launch their studies faster. The new Curebase digital therapeutics offering includes features, workflows, and tools built into the company's eClinical platform specifically made for and used in DTx studies. This also includes virtual site models, CRO services, and recruitment tactics tried and tested in digital therapeutic studies, allowing DTx sponsors to quickly launch a study with the confidence of proven execution.

PRODUCT

#software

View Analyst & Ambassador Comments
Go to original news
Jan 26,2023

Sharecare launches VR program to improve well-being of American workforce and bring innovation to exercise

Sharecare, the digital health company that helps people manage all their health in one place, today announced the launch of Get Active, a new program to help employers encourage exercise among their workforces in a fun, approachable, and accessible way, using the immersive power of virtual reality (VR). In a pilot conducted in late 2022 with Lennar Corporation, Sharecare's Get Active program generated promising results with an engagement rate of 82% and a 280% increase in average weekly exercise minutes per person compared to pre-program.

PRODUCT

#coaching

#virtual reality

View Analyst & Ambassador Comments
Go to original news
Jan 09,2020

Two leading university hospitals implement Kaiku Health in Central Europe

Kaiku Health is strengthening its foothold in Central Europe as the Geneva University Hospitals (HUG) in Switzerland and University Hospital Schleswig-Holstein Lübeck in Germany will implement Kaiku Health in the symptom management and patient-reported outcome monitoring of their cancer patients. Kaiku Health was piloted at the Geneva University Hospitals (HUG) in 2019. The platform will be gradually provided for all patients who receive chemotherapy for local or metastatic breast, colorectal or lung cancer.

COLLABORATION PARTNERSHIP

#institution

#rpm

View Analyst & Ambassador Comments
Go to original news
Subscribe to ONCOLOGY